结扎器材市场 - 全球产业规模、份额、趋势、机会、预测：按产品、应用、手术类型、最终用途、地区和竞争对手划分，2021-2031年

全球结扎器市场预计将从 2025 年的 20.7 亿美元成长到 2031 年的 31.1 亿美元，复合年增长率为 7.02%。

这些专用医疗器械对于外科医生在手术过程中封闭组织束和血管、止血以及防止内渗至关重要。市场成长的主要驱动力是全球开放性手术和微创手术数量的不断增加。人口老化以及心血管疾病和癌症等慢性疾病发生率的上升，使得这一趋势不可避免。例如，美国癌症协会估计，到2025年，美国将新增2,041,910例癌症病例，这进一步推动了这些器械在肿瘤切除等重要手术中需求的成长。

儘管对这些设备的需求日益增长，但由于一次性器械的高昂采购成本，市场面临巨大的障碍。这些成本会对医院预算造成沉重负担，从而限制了在财政拮据的医疗系统中进行采购。儘管全球医疗保健领域对高效止血设备的临床需求持续成长，但这项经济因素仍是可能限制市场准入的重大挑战。

市场驱动因素

微创手术的日益普及是全球结扎器械市场的主要驱动力。为了改善患者预后并缩短住院时间，外科医生越来越多地采用机器人辅助手术和腹腔镜手术，这些手术需要使用专为狭窄空间设计的专用结扎器械。这些手术需要精准止血，直接推动了内视镜结扎夹和结扎器械的购买。根据直觉外科公司（Intuitive Surgical）于2025年1月发布的2024年第四季及全年收益快报，2024年全球使用达文西手术系统的手术量同比增长约17%，显示在复杂手术中，人们越来越依赖使用结扎器进行有效组织控制的先进技术。

同时，受慢性病和文明病率上升的推动，全球需要止血管理的介入手术数量正在增加。在心血管疾病等疾病中，手术修復往往至关重要，因此，无论是开放性手术手术或微创手术，对结扎器械的需求仍然强劲。根据美国心臟协会于2024年1月发布的《2024年心臟病和中风统计数据》，心血管疾病仍是全球首要死因，每年约有1,991万人死于心血管疾病。为了满足这一手术需求，领先的医疗技术公司公布了强劲的财务表现。例如，Medtronic公司于2024年5月发布的《2024财年财务业绩报告》显示，其医疗手术产品组合的收入达到84.17亿美元，较去年同期成长5.4%。

市场挑战

一次性结扎器械的高昂采购成本是全球结扎器械市场扩张的主要障碍。虽然这些一次性器械对于感染控制和提高手术效率至关重要，但其高昂的价格给医疗机构带来了沉重的经济负担。当医院面临预算紧张时，持续采购大量一次性耗材的成本迫使管理者大幅削减采购，或选择更便宜但较旧的替代方案。这种经济负担在资源本就有限的小规模诊所和发展中地区尤其严重，直接导致这些地区无法采购到先进的结扎器械。

近期产业数据显示，医疗机构营运成本飙升，进一步印证了这种经济压力。根据美国医院协会2024年发布的《医疗服务成本》报告，耗材成本占医院总支出的13%，而医院总支出增加了5.1%，远高于整体通膨率。耗材上的过度支出限制了用于引进昂贵手术器械的资金。因此，随着医疗系统优先控製成本，市场成长放缓，采用更新、更昂贵的结扎技术也被搁置。

市场趋势

随着医疗机构越来越多地将低至中等复杂程度的手术从传统医院转移到门诊手术中心（ASC），这种转变正在从根本上改变结扎器械的使用模式。这种结构性转变的驱动力在于提高营运效率和控製成本，促使门诊机构采购专业且经济高效的结扎器械，以确保快速止血，而无需承担医院大规模库存的额外开销。由于这些中心优先考虑高处理能力，因此对可靠的、一次性使用的血管夹和专为简化工作流程而设计的施用器的需求正在加速成长。领先的医疗机构营运商的财务数据也印证了这项转变。根据泰尼特医疗（Tenet Healthcare）于2025年2月发布的“2024年第四季度及全年业绩累计”，由联合外科伙伴国际公司（United Surgical Partners International）运营的门诊运营部门2024年的净营业收入为45亿美元，较上年度的39亿美元大幅增长。这反映了对门诊手术护理日益增长的需求。

同时，内视镜结扎技术的进步正在提升市场价值，因为它克服了传统金属夹在复杂微创手术中的限制。製造商正积极研发先进的聚合物和自锁夹，这些夹子具有更高的安全性和触觉回馈。这些特性对于防止复杂腹腔镜手术过程中夹子脱落至关重要。这项技术革新正促使外科医生从传统的机械方法转向现代化的工程结扎解决方案，从而最大限度地减少血管损伤和手术时间。这些先进器械的强劲商业性接受度从公司近期的业绩指标中可见一斑。根据泰利福（Teleflex）于2025年3月发布的“2024年第四季度财务业绩报告”，其外科部门在不外汇影响的情况下实现了12.3%的收入增长，这主要归功于公司先进结扎产品组合和手术器械的持续普及。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：结扎器械的全球市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品特定（适用设备、配件）
  • 依应用领域（消化/腹部手术、妇科手术、心臟/胸腔外科手术、泌尿系统手术、其他）
  • 手术类型（微创手术、开放性手术）
  • 依最终用户（医院、门诊手术中心）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美结扎器械市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲结扎器械市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区结扎器材市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲结扎器材市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲结扎器械市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球结扎器材市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic Plc
• The Cooper Companies, Inc.
• Conmed Corporation
• B Braun Melsungen AG
• Teleflex Incorporated
• Olympus Corporation
• Ethicon, Inc.
• Sinolinks Medical Innovatoin, Inc.
• Duomed Group
• Leo Medical Co.,Ltd.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Ligation Devices Market is projected to expand from a valuation of USD 2.07 Billion in 2025 to reach USD 3.11 Billion by 2031, registering a Compound Annual Growth Rate (CAGR) of 7.02%. These specialized medical instruments are essential for surgeons to seal tissue bundles or blood vessels, thereby achieving hemostasis and preventing internal leakage during medical interventions. The market's growth is largely driven by the rising global volume of both open and minimally invasive surgeries, a trend necessitated by an aging demographic and the increasing incidence of chronic conditions such as cardiovascular diseases and cancer. For instance, the American Cancer Society estimates that 2,041,910 new cancer cases will be diagnosed in the United States in 2025, underscoring the growing need for surgical tumor removal where these tools are critical.

Despite the rising demand for these devices, the market faces a significant hurdle regarding the high acquisition costs of disposable instruments. These costs can place a heavy burden on hospital budgets, thereby restricting procurement within healthcare systems that operate under financial constraints. This economic factor remains a notable challenge, potentially limiting market access even as the clinical necessity for efficient hemostatic devices continues to grow across the global healthcare landscape.

Market Driver

The widespread adoption of minimally invasive surgical procedures serves as a primary catalyst for the global ligation devices market. Driven by the goal of improving patient outcomes and reducing hospital stays, surgeons are increasingly utilizing robotic-assisted and laparoscopic techniques that require specialized ligation instruments designed for narrow access. These procedures demand precise hemostasis, directly boosting the procurement of endoscopic clips and appliers. Data from Intuitive Surgical's "Preliminary Fourth Quarter and Full Year 2024 Results" in January 2025 indicates that worldwide procedures using da Vinci systems grew by approximately 17% in 2024 compared to the previous year, highlighting the expanding reliance on advanced technologies utilizing ligation devices for effective tissue management during complex operations.

Simultaneously, the rising global prevalence of chronic and lifestyle-related diseases is increasing the volume of surgical interventions that require hemostatic control. Conditions such as cardiovascular diseases often mandate surgical repair, sustaining a high baseline demand for ligation tools in both open and minimally invasive settings. According to the American Heart Association's "Heart Disease and Stroke Statistics 2024 Update" from January 2024, cardiovascular disease remains the leading cause of death globally, accounting for approximately 19.91 million deaths annually. To support this surgical demand, major medical technology companies report strong financial performance; for example, Medtronic's May 2024 "Fiscal Year 2024 Financial Results" showed that its Medical Surgical Portfolio generated $8.417 billion in revenue, reflecting a 5.4% increase over the prior year.

Market Challenge

The high acquisition costs of disposable ligation instruments constitute a significant barrier to the expansion of the Global Ligation Devices Market. Although these single-use tools are vital for infection control and operational efficiency, their premium pricing creates substantial financial pressure on healthcare facilities. When hospitals face tight budget constraints, the recurring expense of purchasing high-volume disposable supplies forces administrators to strictly limit procurement or opt for less expensive, older alternatives. This financial strain is particularly acute in smaller clinics and developing regions, where resource allocation is already restricted, directly reducing the volume of advanced ligation devices purchased.

This economic pressure is further evidenced by recent industry data highlighting the escalating operational costs faced by medical providers. The American Hospital Association's "Cost of Caring" report released in 2024 indicates that supply costs accounted for 13% of total hospital expenses, with overall hospital expenses growing by 5.1%, significantly outpacing the general inflation rate. Such elevated spending on supplies limits the capital available for adopting premium surgical tools. Consequently, the market experiences dampened growth rates as healthcare systems prioritize cost containment over the adoption of newer, albeit more expensive, ligation technologies.

Market Trends

The migration of procedures to Ambulatory Surgical Centers is fundamentally reshaping the consumption patterns of ligation devices, as healthcare providers increasingly move low-to-mid complexity surgeries out of traditional hospital settings. This structural shift is driven by the need for operational efficiency and cost containment, prompting ambulatory facilities to procure specialized, cost-effective ligation tools that ensure rapid hemostasis without the overhead of extensive hospital inventory. These centers prioritize high-volume throughput, thereby accelerating the demand for reliable, single-fire ligation clips and applicators designed for streamlined workflows. This transition is substantiated by financial data from major facility operators; according to Tenet Healthcare's "Fourth Quarter and Full Year 2024 Results" in February 2025, the Ambulatory Care segment operated by United Surgical Partners International generated $4.5 billion in net operating revenues for 2024, a significant increase from $3.9 billion the previous year, reflecting the intensifying volume of outpatient surgical care.

Concurrently, advancements in endoscopic ligation techniques are fueling market value by addressing the limitations of traditional metallic clips in complex minimally invasive procedures. Manufacturers are aggressively innovating to develop advanced polymer and self-locking clips that offer superior security and tactile feedback, which are critical for preventing dislodgement during intricate laparoscopic maneuvers. This technological evolution encourages surgeons to upgrade from legacy mechanical methods to modern, engineered ligation solutions that minimize vessel trauma and operative time. The robust commercial reception of these advanced instruments is evident in recent corporate performance metrics; Teleflex Incorporated's "Fourth Quarter 2024 Earnings Report" from March 2025 noted that its Surgical segment achieved a 12.3% growth in revenue on a constant currency basis, a performance largely attributed to the sustained adoption of its advanced ligation portfolio and surgical instruments.

Key Market Players

• Medtronic Plc
• The Cooper Companies, Inc.
• Conmed Corporation
• B Braun Melsungen AG
• Teleflex Incorporated
• Olympus Corporation
• Ethicon, Inc.
• Sinolinks Medical Innovatoin, Inc.
• Duomed Group
• Leo Medical Co.,Ltd.

Report Scope

In this report, the Global Ligation Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ligation Devices Market, By Product

• Appliers
• Accessories

Ligation Devices Market, By Application

• Gastrointestinal and abdominal surgery
• Gynecological surgery
• Cardiothoracic surgery
• Urological Surgery
• Other

Ligation Devices Market, By Procedure Type

• MIS
• Open Surgery

Ligation Devices Market, By End-use

• Hospitals
• Ambulatory Surgical Centers

Ligation Devices Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ligation Devices Market.

Available Customizations:

Global Ligation Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ligation Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Appliers, Accessories)
  • 5.2.2. By Application (Gastrointestinal and abdominal surgery, Gynecological surgery, Cardiothoracic surgery, Urological Surgery, Other)
  • 5.2.3. By Procedure Type (MIS, Open Surgery)
  • 5.2.4. By End-use (Hospitals, Ambulatory Surgical Centers)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Ligation Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Procedure Type
  • 6.2.4. By End-use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Ligation Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Procedure Type
      • 6.3.1.2.4. By End-use
  • 6.3.2. Canada Ligation Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Procedure Type
      • 6.3.2.2.4. By End-use
  • 6.3.3. Mexico Ligation Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Procedure Type
      • 6.3.3.2.4. By End-use

7. Europe Ligation Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Procedure Type
  • 7.2.4. By End-use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Ligation Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Procedure Type
      • 7.3.1.2.4. By End-use
  • 7.3.2. France Ligation Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Procedure Type
      • 7.3.2.2.4. By End-use
  • 7.3.3. United Kingdom Ligation Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Procedure Type
      • 7.3.3.2.4. By End-use
  • 7.3.4. Italy Ligation Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Procedure Type
      • 7.3.4.2.4. By End-use
  • 7.3.5. Spain Ligation Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Procedure Type
      • 7.3.5.2.4. By End-use

8. Asia Pacific Ligation Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Procedure Type
  • 8.2.4. By End-use
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Ligation Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Procedure Type
      • 8.3.1.2.4. By End-use
  • 8.3.2. India Ligation Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Procedure Type
      • 8.3.2.2.4. By End-use
  • 8.3.3. Japan Ligation Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Procedure Type
      • 8.3.3.2.4. By End-use
  • 8.3.4. South Korea Ligation Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Procedure Type
      • 8.3.4.2.4. By End-use
  • 8.3.5. Australia Ligation Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Procedure Type
      • 8.3.5.2.4. By End-use

9. Middle East & Africa Ligation Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Procedure Type
  • 9.2.4. By End-use
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Ligation Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Procedure Type
      • 9.3.1.2.4. By End-use
  • 9.3.2. UAE Ligation Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Procedure Type
      • 9.3.2.2.4. By End-use
  • 9.3.3. South Africa Ligation Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Procedure Type
      • 9.3.3.2.4. By End-use

10. South America Ligation Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Procedure Type
  • 10.2.4. By End-use
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Ligation Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Procedure Type
      • 10.3.1.2.4. By End-use
  • 10.3.2. Colombia Ligation Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Procedure Type
      • 10.3.2.2.4. By End-use
  • 10.3.3. Argentina Ligation Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Procedure Type
      • 10.3.3.2.4. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Ligation Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. The Cooper Companies, Inc.
• 15.3. Conmed Corporation
• 15.4. B Braun Melsungen AG
• 15.5. Teleflex Incorporated
• 15.6. Olympus Corporation
• 15.7. Ethicon, Inc.
• 15.8. Sinolinks Medical Innovatoin, Inc.
• 15.9. Duomed Group
• 15.10. Leo Medical Co.,Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer